Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

First-in-human data on MLN-0264 in advanced gastrointestinal cancer reported

July 8, 2013

Initiation of a phase III study of ITK-1 in patients with prostate cancer

July 5, 2013

Etubics receives NIH grant to develop HPV vaccine

July 5, 2013

FDA grants priority review for obinutuzumab BLA

July 4, 2013

EMA gives Provenge a positive opinion

July 3, 2013

Seattle Genetics and Agensys set to develop additional antibody-drug conjugate

July 3, 2013

MorphoSys and Celgene create alliance to develop MOR-202 for multiple myeloma

July 1, 2013

VivaMab and ADC Therapeutics enter licensing agreement for ADC candidate

July 1, 2013

Japan approves Perjeta for HER2-positive inoperable or recurrent breast cancer

June 28, 2013

EMD Serono creates immune-oncology research and early development platform

June 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...